News Opinion Editor's Corner ACC 2016 Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016 Shelley Wood April 13, 2016
News Conference News ACC 2016 New Insights Into MitraClip Performance in Both Functional and Degenerative MR Subtypes, as Use Expands Shelley Wood April 12, 2016
News Conference News ACC 2016 Hints of What’s to Come in New Coronary Revascularization AUC Caitlin E. Cox April 12, 2016
News Conference News ACC 2016 CT Angiography and Stress Testing: Prognostic Value Differs Between Women and Men Caitlin E. Cox April 08, 2016
News Conference News ACC 2016 CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results Shelley Wood April 08, 2016
News Conference News ACC 2016 Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes Michael O'Riordan April 07, 2016
News Conference News ACC 2016 Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon Michael O'Riordan April 06, 2016
News Conference News ACC 2016 Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why Yael L. Maxwell April 06, 2016
News Conference News ACC 2016 Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure Todd Neale April 05, 2016
News Conference News ACC 2016 STEPATHLON: A Mobile-Based Exercise Program Increased Physical Activity and Promoted Weight Loss Michael O'Riordan April 04, 2016
News Conference News ACC 2016 New-Generation Watchman FLX Device Pulled From European Shelves Over Embolism Concerns Todd Neale April 04, 2016
News Conference News ACC 2016 Involving Low-Risk Patients in Chest Pain Test Decisions Eases Fears, Saves Money Caitlin E. Cox April 04, 2016
News Conference News ACC 2016 Watchman Left Atrial Appendage Closure Device Fares Well in Early Commercial Experience Todd Neale April 03, 2016
News Conference News ACC 2016 TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough? Shelley Wood April 03, 2016
News Conference News ACC 2016 Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH Michael O'Riordan April 03, 2016
News Conference News ACC 2016 When Chosen Wisely, 90-Year-Olds Do Well After TAVR Caitlin E. Cox April 02, 2016
News Conference News ACC 2016 HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not Michael O'Riordan April 02, 2016
News Conference News ACC 2015 ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted Todd Neale March 20, 2015
News Conference News ACC 2015 Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR Yael L. Maxwell March 15, 2015
News Conference News ACC 2015 Anticoagulation With Off-Switch Fails to Improve PCI Outcomes, Sparks Allergic Reactions Todd Neale March 15, 2015